[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-352387-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-352387-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","tertiary-lymphoid-structures-in-the-era-of-cancer-therapy-open-access-meeting-report","Tertiary lymphoid structures in the era of cancer therapy - Open Access Meeting Report","","On September 9th, 2025, the 3rd Workshop on Tertiary lymphoid structures (TLS) took place in Utrecht as a premeeting to CICON2025, focusing on advances reshaping TLS biology, diversity, and clinical relevance. Studies highlight architectural and cellular heterogeneity, distinct functional T-cell profiles despite histological similarity, and implications for patient outcomes. Standardization efforts using pathology-based algorithms support mature TLS identification across cancer types and improve immunotherapy response stratification. Challenges persist in glioblastoma and ovarian cancer where TLS are rare and constrained by local niches. Experimental and technological advances, including vascular-targeted cytokine delivery and high-resolution antigen receptor sequencing, elucidate TLS formation, clonality, fibroblast interactions, and metabolic mechanisms such as GABA-mediated suppression, positioning TLS as dynamic immune hubs influencing prognosis and resistance.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/tertiary-lymphoid-structures-in-the-era-of-cancer-therapy-open-access-meeting-report/352387/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/tertiary-lymphoid-structures-in-the-era-of-cancer-therapy-open-access-meeting-report/352387.png","ImageObject",300,407,{"name":42,"@type":43},"Oliver","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-31","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the key focus of the 3rd Workshop on Tertiary lymphoid structures (TLS) in Utrecht?","Question",{"text":63,"@type":64},"The workshop concentrated on advances in TLS biology, diversity, and clinical significance, including how TLS features relate to therapy and patient outcomes.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How can TLS that look similar under histology still differ functionally?",{"text":68,"@type":64},"Spatial multi-omics shows that histologically similar TLS can contain T cells with distinct functional profiles, which can influence clinical outcomes independently of conventional immune markers.",{"name":70,"@type":61,"acceptedAnswer":71},"What challenges were highlighted for TLS in glioblastoma and ovarian cancer?",{"text":72,"@type":64},"TLS are described as rare, anatomically constrained, and strongly shaped by local tissue niches in these cancers.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},352387,1790337430,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":102,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},8796095461610,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Hernández-Verdin et al.  \nJournal of Experimental & Clinical Cancer Research (2026) 45:48 [https://doi.org/10.1186/s13046-026-03644-3](https://doi.org/10.1186/s13046-026-03644-3)  \nJournal of Experimental & Clinical Cancer Research  \nMEETING REPORT Open Access  \nTertiary lymphoid structures in the era of cancer therapy  \nIsaias Hernández-Verdin1, Anna Dimberg2, Daniela S. Thommen3, Camilla Engblom4, Lucile Vanhersecke5, Karina Silina6, Tullia C. Bruno7,8, Wolf H. Fridman 1, Paola Nisticò9* and Catherine Sautès-Fridman1*  \nAbstract  \nOn September 9th, 2025, the 3rd Workshop on Tertiary lymphoid structures (TLS) took place in Utrecht as premeeting to CICON2025 . Advances in TLS biology, diversity, and clinical significance are rapidly reshaping the field. The studies discussed here reveal the heterogeneity in TLS architecture, cellular composition, functional states, and developmental trajectories, shaped by tumor-specific chemokine gradients. Spatial multi-omics revealed that TLS appearing histologically similar can contain T cells with distinct functional profiles, influencing clinical outcomes independently of conventional immune markers. Efforts toward TLS standardization are gaining attraction through pathology-based algorithms capable of reliably identifying mature TLS across cancer types, supporting reproducible stratification and prediction of immunotherapy response. However, challenges remain in glioblastoma and ovarian cancer, where TLS are rare, anatomically constrained, and strongly influenced by local tissue niches. Experimental models demonstrate that vascular-targeted cytokine delivery can induce TLS formation and promote T cell– dependent tumor control, supporting novel therapeutic avenues. Technological advances, including spatially resolved antigen receptor sequencing, now allow high-resolution mapping of B-and T-cell clonotypes, clonal evolution, and early antigen discovery within TLS. Across cancers, TLS enriched in activated B cells, memory B cells, and plasma cells emerge as key drivers of sustained immune activation. Spatial analyses also reveal interactions between TLS and specific fibroblast or mesenchymal subsets that modulate immunotherapy response. Finally, integrative studies identify tumor-intrinsic metabolic pathways, such as GABA production, that suppress TLS activity and contribute to immunotherapy resistance. Collectively, these findings establish TLS as dynamic, spatially organized immune hubs with broad implications for cancer prognosis and therapy.  \nKeywords Tertiary lymphoid structures, Tumor microenvironment, Immunotherapy, Heterogeneity, Spatial multiomics  \n*Correspondence:  \nPaola Nisticò  \n[paola.nistico@ifo.it](paola.nistico@ifo.it)  \nCatherine Sautès-Fridman  \ncatherine.fridman@crc.jussieu.fr  \n1Centre de Recherche des Cordeliers, Sorbonne Université, INSERM, Université de Paris, Paris 75006, France  \n2Department of Immunology, Genetics and Pathology, Science for Life Laboratory, The Rudbeck Laboratory, Uppsala University, Uppsala, Sweden  \n3Division of Molecular Oncology and Immunology, Oncode Institute, Netherlands Cancer Institute, Amsterdam, The Netherlands  \n4Division of Immunology and Respiratory Medicine, Department of Medicine Solna, Karolinska Institutet, Science for Life Laboratory, Stockholm and Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden  \n5Departement de Biopathologie, Institut Bergonié, Bordeaux, France 6Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology, Zurich, Switzerland  \n7Department of Immunology, University of Pittsburgh, Pittsburgh, PA 15213, USA  \n8Tumor Microenvironment Center, Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA 15213, USA  \n9Tumor Immunology and Immunotherapy Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharin","cbCairPOJkYVLDpb","https://ap.wps.com/l/cbCairPOJkYVLDpb","pdf",1326355,"English","# Abstract\n## Workshop on Tertiary lymphoid structures (TLS)\n## TLS heterogeneity and clinical significance\n## Standardization and computational identification\n## Challenges in specific cancers\n## Mechanistic insights and therapeutic implications","[{\"question\":\"What was the key focus of the 3rd Workshop on Tertiary lymphoid structures (TLS) in Utrecht?\",\"answer\":\"The workshop concentrated on advances in TLS biology, diversity, and clinical significance, including how TLS features relate to therapy and patient outcomes.\"},{\"question\":\"How can TLS that look similar under histology still differ functionally?\",\"answer\":\"Spatial multi-omics shows that histologically similar TLS can contain T cells with distinct functional profiles, which can influence clinical outcomes independently of conventional immune markers.\"},{\"question\":\"What challenges were highlighted for TLS in glioblastoma and ovarian cancer?\",\"answer\":\"TLS are described as rare, anatomically constrained, and strongly shaped by local tissue niches in these cancers.\"}]","Tertiary lymphoid structures in the era of cancer therapy - Open Access Meeting Report | PDF",1790099302,15,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/20f1c71f7a0c626ee9caa360afd30619.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8c37871d5eb3cdac7cb0ea9a3457a793.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c22ba65f786bd4f55045ee0e278cea43.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/20983cebbe993df084230e5d6fad2e8b.webp",980,1306]